戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 hout safety concerns around using aspirin and meeting trial eligibility criteria.
2 ut benefits only to a minority of patients due to stringent eligibility criteria.
3 as implanted sequentially into each eye of patients meeting eligibility criteria.
4 ds identified, 36 articles, relating to 30 studies, met the eligibility criteria.
5 own few patients in higher-resource settings would meet WHO eligibility criteria.
6 logists responded, and 87.1% (825 of 946) of responders met eligibility criteria.
7 adults aged 18 through 60 years were enrolled after meeting eligibility criteria.
8                  We included 18 studies that met our strict eligibility criteria.
9 after symptom onset using standard intravenous thrombolysis eligibility criteria.
10 s; six randomized controlled trials of systemic therapy met eligibility criteria.
11 ralia/New Zealand, and the United States/Latin America, met eligibility criteria.
12 A PET/MRI at 3 T between January 2017 and July 2019 met the eligibility criteria.
13                              Of 37,050 patients who met the eligibility criteria, 529 patients (1.4%) developed symptomat
14                          Two patients did not meet the full eligibility criteria after baseline assessment; therefore, 23
15 uld be consistent in a postcommercial setting, with relaxed eligibility criteria and bridging therapy, is unknown.
16                                    Fifty-eight articles met eligibility criteria and formed the evidentiary basis for the
17 Twenty-six descriptive reports or observational studies met eligibility criteria and formed the evidentiary basis for the
18  pool, lack of robust outcomes data, lack of standard donor eligibility criteria and preservation methods, and logistical
19  potentially appropriate studies, 35 (88%) of which met the eligibility criteria and were included in the final analysis
20                                          Twenty studies met eligibility criteria and were included in the present meta-an
21 mies were performed, only 25 of these fit the predetermined eligibility criteria and were thus included in this retrospec
22           Response was assessed in all patients who met the eligibility criteria and who received at least 8 weeks of the
23                                   140 patients did not meet eligibility criteria, and 535 patients were randomly assigned
24                                                 Determining eligibility criteria, as well as peritransplant and posttrans
25  patients (43%) in this SOC study would not have met ZUMA-1 eligibility criteria because of comorbidities at the time of
26 -line to outline specific team structures, modified patient eligibility criteria, cannulation strategies, and management
27                                                        Some eligibility criteria differed between these studies.
28 r Disease Control and Prevention's recommendations, Medical Eligibility Criteria for Contraceptive Use, provided the stru
29            Of 249 identified abstracts, four trials met our eligibility criteria for inclusion: WAKE-UP, EXTEND, THAWS, a
30              Centers for Medicare & Medicaid Services (CMS) eligibility criteria for lung cancer screening with CT requir
31 ns who are at increased risk of lung cancer but do not meet eligibility criteria for screening, as well as multiple barri
32                          We estimated costs by applying the eligibility criteria for the shorter regimen, and proportiona
33 imultaneous pancreas and kidney (SPK) transplant and define eligibility criteria for those with type 2 diabetes mellitus
34                                                             Eligibility criteria in PARADIGM-HF included New York Heart A
35                                                             Eligibility criteria included age at least 18 years, centrall
36                                                             Eligibility criteria included inadequate response to or intol
37 se items included sampling approaches (n = 15), participant eligibility criteria (n = 6), and model-building procedures (
38                         Of these, 1750 (65%) met all of the eligibility criteria on telephone screening and underwent the
39 CS.Conclusions: This statement identifies the impact of LCS eligibility criteria on vulnerable populations who are at inc
40 the usual care group, on further scrutiny, did not meet all eligibility criteria or withdrew from the study.
41                            Twenty-nine patients who met the eligibility criteria (responders, n = 14, and nonresponders,
42                                  Of the 1,595 PLHIV who met eligibility criteria, the majority (61%) were inpatients, med
43                                   DESIGN , DATA SOURCES AND ELIGIBILITY CRITERIA: We systematically searched databases (M
44                                 All available cases meeting eligibility criteria were enrolled.
45                          Four patients who did not meet the eligibility criteria were excluded.
46                                                             Eligibility criteria were modeled on those for the Early Mani
47                                                             Eligibility criteria were the presence of any thoracic cancer
48  Of 559 full-text studies assessed for eligibility, 116 met eligibility criteria, which included studies describing the i
49                                   Overall, 572 patients met eligibility criteria with 2855 patient-years of follow-up.
50                                           2161 patients met eligibility criteria with 876 (41%) transitioned to oral ther